These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21820306)

  • 21. Antimicrobial activity of liposome encapsulated cyclo(L-tyrosyl-L-prolyl).
    Kilian G; Tshanga SS; Oidu B; Milne PJ
    Pharmazie; 2011 Jun; 66(6):421-3. PubMed ID: 21699080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of cyclic disulfide-bonded antibacterial peptides on the basis of the alpha helical domain of Tenecin 1, an insect defensin.
    Ahn HS; Cho W; Kim JM; Joshi BP; Park JW; Lohani CR; Cho H; Lee KH
    Bioorg Med Chem; 2008 Apr; 16(7):4127-37. PubMed ID: 18243710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii.
    Conlon JM; Ahmed E; Pal T; Sonnevend A
    Peptides; 2010 Oct; 31(10):1806-10. PubMed ID: 20603168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.
    Pál T; Sonnevend A; Galadari S; Conlon JM
    Regul Pept; 2005 Jul; 129(1-3):85-91. PubMed ID: 15927702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel gratisin derivatives with high antimicrobial activity and low hemolytic activity.
    Tamaki M; Imazeki Y; Shirane A; Fujinuma K; Shindo M; Kimura M; Uchida Y
    Bioorg Med Chem Lett; 2011 Jan; 21(1):440-3. PubMed ID: 21095123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of ion-selective channel using cyclic tetrapeptides.
    Suga T; Osada S; Kodama H
    Bioorg Med Chem; 2012 Jan; 20(1):42-6. PubMed ID: 22172312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the isomers of cyclo(Trp-Pro) on heart and ion-channel activity.
    Jamie H; Kilian G; Dyason K; Milne PJ
    J Pharm Pharmacol; 2002 Dec; 54(12):1659-65. PubMed ID: 12542896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of selected cyclic dipeptides.
    Graz M; Hunt A; Jamie H; Grant G; Milne P
    Pharmazie; 1999 Oct; 54(10):772-5. PubMed ID: 10563376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of antibacterial and hemolytic activities of an amphipathic peptide antibiotic.
    Qin C; Zhong X; Bu X; Ng NL; Guo Z
    J Med Chem; 2003 Nov; 46(23):4830-3. PubMed ID: 14584933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of arginine- and tryptophan-rich cyclic hexapeptides with Escherichia coli membranes.
    Junkes C; Wessolowski A; Farnaud S; Evans RW; Good L; Bienert M; Dathe M
    J Pept Sci; 2008 Apr; 14(4):535-43. PubMed ID: 17985396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, beta-lactam antibiotics and antibiotic resistance mechanisms.
    Grail BM; Payne JW
    J Mol Recognit; 2002; 15(3):113-25. PubMed ID: 12203837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labaditin, a cyclic peptide with rich biotechnological potential: preliminary toxicological studies and structural changes in water and lipid membrane environment.
    Barbosa SC; Cilli EM; Dias LG; Stabeli RG; Ciancaglini P
    Amino Acids; 2011 Jan; 40(1):135-44. PubMed ID: 20563613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
    Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
    J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides.
    Urakawa H; Yamada K; Komagoe K; Ando S; Oku H; Katsu T; Matsuo I
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1771-5. PubMed ID: 20138759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
    Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
    Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity.
    Jacob B; Rajasekaran G; Kim EY; Park IS; Bang JK; Shin SY
    Amino Acids; 2016 May; 48(5):1241-51. PubMed ID: 26795535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian cell toxicity and candidacidal mechanism of Arg- or Lys-containing Trp-rich model antimicrobial peptides and their d-enantiomeric peptides.
    Nan YH; Lee SH; Kim HJ; Shin SY
    Peptides; 2010 Oct; 31(10):1826-31. PubMed ID: 20621141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic studies on cyclic octapeptides: Yunnanin F and Hymenistatin.
    Poojary B; Belagali SL
    Eur J Med Chem; 2005 Apr; 40(4):407-12. PubMed ID: 15804540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.